Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
03/2008
03/13/2008WO2007128899A3 Stable c-glycoside sugar and c-glycoconjugate mimetics, method for preparing same and uses thereof in particular in cosmetics and drugs
03/13/2008US20080064661 Dihydroxyl compounds and compositions for cholesterol management and related uses
03/12/2008EP1896440A1 Synthesis of hydroquinone derivatives
03/11/2008US7342124 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
03/11/2008CA2310664C Substituted 2-aminoacetamides and the use thereof
03/06/2008WO2008026140A2 Malodor counteracting compositions and method for their use
03/06/2008US20080058537 Cyclopenta[b]naphthalene derivatives
03/06/2008US20080058379 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
03/05/2008EP1893571A2 Process for production of 4-biphenylyazetidin-2-ones
03/05/2008CN101137637A Process for the preparation of (r)-4,4-dialkoxy-pyran-3-ols such as (r)-4,4-dimethoxy-pyran-3-ol
03/05/2008CN101134584A Method for waste recovering and handling in maltol production
03/05/2008CN100372817C Total triterpenoid extract fine thim asterium sponge and its preparation process and application thereof
02/2008
02/28/2008WO2008024963A1 Benzene, pyridine, and pyridazine derivatives
02/28/2008WO2008024961A1 Dihydropyridazine, tetrahydropyridine, chromanone, and dihydronaphthalenone derivatives as heat-shock protein 90 inhibitors
02/28/2008WO2008024302A2 Compounds for treating proliferative disorders
02/28/2008CA2661440A1 Compounds for treating proliferative disorders
02/27/2008EP1891026A2 Cycloalkylidene compounds as selective estrogen receptor modulators
02/27/2008CN101133010A Process and intermediate compounds useful in the preparation of statins
02/26/2008US7335799 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X
02/26/2008US7335689 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy
02/26/2008US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide
02/26/2008CA2415963C Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives
02/21/2008WO2008019746A1 Tetrahydropyran compounds
02/21/2008WO2008019477A1 Viral polymerase inhibitors
02/21/2008US20080045516 Viral Polymerase Inhibitors
02/21/2008DE102007033585A1 New tetrahydropyran compound useful as a component in liquid crystal medium, which is useful for electro-optical components such as sensors, twisted nematic-, super twisted nematic-, in-plane switching- and another active matrix- displays
02/21/2008DE102007033584A1 New cyclohexene-compounds useful as a component in a liquid crystal medium
02/21/2008CA2660555A1 Viral polymerase inhibitors
02/20/2008EP1888552A1 CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
02/20/2008EP1888551A1 Crystalline forms of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((r)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
02/20/2008EP1888509A1 Benzoyl-substituted serine amides
02/20/2008EP1620423B1 Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
02/20/2008EP1597266A4 A non-cryogenic process for forming glycosides
02/20/2008CN101128436A 甘氨酸衍生物及其用途 Glycine derivatives and their use
02/20/2008CN101125840A Grignard reagent synthesis reaction solvent in maltol production
02/20/2008CN101125839A Processing method for mother liquid in maltol production and device thereof
02/20/2008CN101125838A Reclaiming and processing method for solvent in maltol production and device thereof
02/20/2008CN101125837A C-glycosides type slycolipid compounds and use thereof
02/20/2008CN100369907C Method for producing epoxy propane
02/19/2008US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/13/2008CN101124211A Antibiotic FKI-1778 and its production method
02/12/2008US7329330 Divided wall structure; rectifier and stripping zone
02/07/2008WO2008015240A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
02/07/2008US20080032914 Beta-Substituted Tetrahdropyrana (On) S And Method For The Synthesis And The Use Thereof
02/07/2008CA2658547A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
02/06/2008EP1883634A2 Process for preparing simvastatin and intermediates thereof
02/06/2008EP1883402A2 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
02/05/2008US7326798 Reacting 2-{[(S)-2-methylpent-4-in-1-yl]oxy}-3,4,5,6-tetrahydro-2H-pyrane with acetaldehyde to produce 2RS,6S)-6-Methyl-7-[(RS)-(3,4,5,6-tetrahydro-2H-pyran-2-yl)oxy]hept-3-in-2-ol
01/2008
01/31/2008WO2008012372A1 Process for the preparation of candesartan cilexetil form i
01/31/2008WO2008012371A1 Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography
01/31/2008US20080027115 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
01/31/2008US20080026943 Phenyl-Substituted [1,2]-Oxazine-3,5-Dione and Dihydropyrone Derivatives
01/30/2008CN101115711A Diacylglycerol acyltransferase inhibitors
01/30/2008CN101113146A Process for the separation of blood fat recovery purpose-made monascus active ingredient
01/29/2008CA2393057C Process for recovering pravastatin from a fermentation broth
01/24/2008WO2008009897A1 Process for preparing pregabalin and its opposite enantiomer
01/24/2008WO2008009118A1 4-hydroxythiobenzamide derivatives of drugs
01/24/2008WO2007136948A3 Cyclic hydrofluoroether compounds and processes for their preparation and use
01/24/2008US20080021061 Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
01/24/2008DE102006031143A1 Fluortenside Fluorosurfactants
01/24/2008CA2658429A1 4-hydroxythiobenzamide derivatives of drugs
01/23/2008EP1567498B1 Mandelic acid derivatives
01/22/2008US7321046 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
01/22/2008US7320974 Cytoskeletal active compounds, compositions and use
01/17/2008WO2008008442A1 Preparation and utility of hmg-coa reductase inhibitors
01/17/2008WO2007052309A3 Improved process for manufacturing statins
01/17/2008DE102007028712A1 Preparation of 5,6-dihydro-2H-pyran comprises reacting 1,3-butadiene and formaldehyde in the presence of a solid catalyst, in gaseous phase at specific temperature and pressure
01/16/2008EP1687288B1 Substituted aryl cycloalkanol derivatives and methods of their use
01/16/2008CN101107230A Process for production of 5-chloro-2,4-dihydroxypyridine
01/16/2008CN101106985A 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
01/16/2008CN100362010C Mevalonic acid derivative
01/15/2008US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism
01/15/2008US7319099 Benzoyl-piperazine derivatives
01/10/2008US20080009462 Metabolically Stable Alkoxyalkyl Esters of Antiviral or Antiproliferative Phosphonates, Nucleoside Phosphonates and Nucleoside Phosphates
01/10/2008US20080009450 Genipin derivatives and uses thereof
01/09/2008CN100360515C Lingshui alcohol with anti-cancer activity, its preparation and use
01/08/2008CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
01/03/2008WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin
01/03/2008WO2008000407A1 Inhibitors of cxcr2
01/03/2008US20080004415 Non-linear optically active molecules, their synthesis, and use
01/03/2008US20080004336 Crystal structures of sglt2 inhibitors and processes for preparing same
01/02/2008EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
01/02/2008EP1656361B1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors
01/02/2008EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
01/02/2008CN100358891C Pyranones useful as ATM inhibitors
01/02/2008CN100358884C Simple synthesis of kojic acid diester
01/01/2008US7314943 2,5-disubstitution; enyne metathesis cyclization preparation; aroma substances or intermediates
01/01/2008US7314942 Reactrting butyrolactone or valerolactone with formaldehyde;heating under critical temperature, critical pressure
01/01/2008US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders
12/2007
12/27/2007WO2007148676A1 Therapeutic or prophylactic agent for leukemia
12/27/2007WO2007148648A1 Therapeutic or prophylactic agent for multiple sclerosis
12/27/2007US20070299263 Hydroxy Alkyl Amines
12/27/2007US20070299052 Inhibitors of IAP
12/27/2007US20070298968 2,4,6-Phenyl-Substituted Cyclic Ketoenols
12/27/2007CA2655801A1 Therapeutic or prophylactic agent for leukemia
12/27/2007CA2655573A1 Therapeutic or prophylactic agent for multiple sclerosis
12/26/2007EP1869060A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
12/26/2007CN101092409A C-aryl glucoside sglt2 inhibitors and method
12/25/2007US7312048 Recombinant production of novel polyketides
12/21/2007WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 129